Eisai
4523.T
#2300
Rank
โ‚น784.47 B
Marketcap
โ‚น2,780
Share price
-0.60%
Change (1 day)
3.52%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น82.96. In 2026 the company made an earnings per share (EPS) of โ‚น82.60 a decrease over its 2025 EPS that were of โ‚น104.61.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026โ‚น82.60-21.04%
2025โ‚น104.6111.85%
2024โ‚น93.52-32.63%
2023โ‚น138.825.52%
2022โ‚น131.56-74.01%
2021โ‚น506.13-66.58%
2020โ‚น1,51498.24%
2019โ‚น763.8417.01%
2018โ‚น652.7937.78%
2017โ‚น473.80-27.62%
2016โ‚น654.6235.33%
2015โ‚น483.72-2.82%
2014โ‚น497.77-27.66%
2013โ‚น688.14-27.49%
2012โ‚น949.07-12.67%
2011โ‚น1,08788.08%
2010โ‚น577.85-11.06%
2009โ‚น649.72-390.15%
2008-โ‚น223.93-127.78%
2007โ‚น806.19347.11%
2006โ‚น180.314.38%
2005โ‚น172.757.4%
2004โ‚น160.8643.03%
2003โ‚น112.4725.09%
2002โ‚น89.9152.67%
2001โ‚น58.8969.76%
2000โ‚น34.69